A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
about
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyA model to integrate patient preferences into delivery systems: the importance of end-user input into pulmonary delivery.Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol.Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences
P2860
A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A Preference Study of Two Plac ...... aler (DPI) versus DISKUS® DPI.
@en
A Preference Study of Two Plac ...... D: ELLIPTA® Dry Powder Inhaler
@nl
type
label
A Preference Study of Two Plac ...... aler (DPI) versus DISKUS® DPI.
@en
A Preference Study of Two Plac ...... D: ELLIPTA® Dry Powder Inhaler
@nl
prefLabel
A Preference Study of Two Plac ...... aler (DPI) versus DISKUS® DPI.
@en
A Preference Study of Two Plac ...... D: ELLIPTA® Dry Powder Inhaler
@nl
P2093
P2860
P1476
A Preference Study of Two Plac ...... aler (DPI) versus DISKUS® DPI.
@en
P2093
Chang-Qing Zhu
Edward M Kerwin
George Georges
Richard H Stanford
Suyong Yun Kirby
P2860
P304
P356
10.3109/15412555.2015.1057274
P407
P577
2015-10-30T00:00:00Z